Dalteparin
| Dalteparin | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 1134.90 g/mol [1] |
| Solubility | 1.08e+01 g/L [1] |
| Predicted LogP | -10.8 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C26H42N2O37S5 |
| IUPAC name | 6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid |
| SMILES | CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O |
| InChI | InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54) |
| InChIKey | HTTJABKRGRZYRN-UHFFFAOYSA-N |
| CAS number | 9005-49-6 |
| PubChem CID | 772 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 3-5 hours subcutaneous; 2.1-2.3 hours IV |
| Excretion | Kidney |
| Routes of administration | Subcutaneous |
Dalteparin (also known as GlyTouCan:G90061MS, G90061ms, Clexane, Parvoparin, α-Heparin, LMWH, Sandoparin, Pabyrin, Subeparin or Triofiban) is a anticoagulant substance.
Chemistry
Stereochemistry []
Dalteparin is a racemic mixture.
Druglikeness
Lipinski's rule of five
Dalteparin doesn't match Lipinski's rule of five (violations: 3).Pharmacology
Medical side effects []
66 side effects listed on drug labels in SIDER 4.1 (LMWH).
- Dyspnoea
- Nausea
- Confusional state
- Feeling abnormal
- Diarrhoea
- Haemorrhage
- Major bleed
- Haemoglobin
- Anaemia
- Oedema
- Ecchymosis
- Thrombocytopenia
- Cardiac failure
- Haemorrhage intracranial
- Pneumonia
- Atrial fibrillation
- Pulmonary oedema
- Body temperature increased
- Haematuria
- Oedema peripheral
- Injection site haemorrhage
- Alopecia
- Eosinophilia
- Headache
- Haematoma
- Hyperkalaemia
- Hyperlipidaemia
- Hypersensitivity
- Hypertriglyceridaemia
- Blood triglycerides increased
- Inflammation
- Nodule
- Osteoporosis
- Pruritus
- Purpura
- Vascular purpura
- Shock
- Thrombosis
- Urticaria
- Vasculitis
- Skin necrosis
- Skin exfoliation
- Rash pustular
- Dermatitis bullous
- Diabetes mellitus
- Anaphylactic shock
- Anaphylactoid reaction
- Paralysis
- Dermatitis atopic
- Thrombocytosis
- Local reaction
- Spinal haematoma
- Haemorrhagic anaemia
- Cholestatic liver injury
- Liver disorder
- Hepatocellular injury
- Foetor hepaticus
- Pain
- Erythema
- Injection site pain
- Aspartate aminotransferase increased
- Alanine aminotransferase increased
- Malaise
- Epidural haemorrhage
- Electrocardiogram ST segment elevation
- Myocardial infarction
Indications
- Angina unstable
- Deep vein thrombosis
- Myocardial infarction
- Pulmonary embolism
- ST segment elevation myocardial infarction
Subjective effects []
| 0xea / Dalteparin [] | |
|---|---|
Routes:
| |
Legal status []
- Australia: Dalteparin is a Schedule 4.
- United States: Dalteparin is Prescription only.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 772, Dalteparin. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/772
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:52:07 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 09:52:03 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:52:03 |
| gsrs | missing (no UNII) | 2026-11-20 09:52:03 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014551) | 2026-11-20 09:52:03 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:52:06 |
| pubchem | ok | 2026-11-20 09:52:03 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:52:03 | |
| sider | ok | 2026-11-20 09:52:03 |
| structure | ok | 2026-11-20 09:52:03 |
| wikipedia | ok | 2026-11-20 09:52:03 |